Moderní technologie a způsob jejich využívání pro optimalizaci léčby diabetu 1. i 2. typu v praxi

Abstract

This overview has summarized the authors' experience with intensive selfmonitoring including an evaluation of glucometers' reliability. A ten-point glycaemic profile and continuous monitoring are flexible indicators of therapeutic effectiveness and the dawn phenomenon in persons with type 1 or type 2 diabetes mellitus. A personal glucometer, selfmonitoring and education are now becoming prerequisites for successful intensive insulin treatment particularly when using the insulin pump. These modern methods should be implemented into practice. The following types of glucometers have been subsequently tested at the authors' workplaces: One Touch (Lifescan, GB), Optium (Medisense/Abbott, GB), Card (Medisense/Abbott, GB), Advance (Hypoguard, GB), Linus (Agamatrix, USA), Contourlink (Bayer, BRD) a CALLA (Wellion, Austria). Accuracy andrepeatability of results oéf tested glucometers allow their implementation into practice.